Brief: Kane Biotech Inc QTRLY Loss Per Share Of $0.01
02/04/2020 22:01
Kane Biotech Inc KNE.V :
* KANE BIOTECH ANNOUNCES FOURTH QUARTER AND FULL YEAR 2019
FINANCIAL RESULTS
* KANE BIOTECH INC QTRLY LOSS PER SHARE OF $0.01
Source text for Eikon: ID:nGNXGr9jl
Further company coverage: KNE.V
Recent news on Kane Biotech
See all newsBrief: Kane Biotech Announces FDA 510(K) Clearance For Revyve® Antimicrobial Skin And Wound Cleanser
Brief: Kane Biotech Restarts Commercial Activities And Strengthens North American Management
Brief: Kane Biotech Completes U.S. FDA 510(K) Submission For Revyve Antimicrobial Wound Cleanser
Brief: Kane Biotech Announces Second Quarter 2025 Financial Results
Brief: Kane Biotech provides further corporate update